Advertisement

PharmacoEconomics & Outcomes News

, Volume 842, Issue 1, pp 4–4 | Cite as

Aflibercept in neovascular AMD: better outcomes, acceptable cost

Clinical study
  • 6 Downloads

Reference

  1. Carrasco J, et al. Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies. Advances in Therapy : 14 Nov 2019. Available from: URL: http://doi.org/10.1007/s12325-019-01147-6

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations